New era of biotechnology: AI and policy drive, innovative drug research and development to welcome the golden age

In this era of rapid development, the biotech industry is changing at an unprecedented speed. Recently, with the successful conclusion of the 2025 China Biological Fermentation Industry Technology Conference and the upcoming convening of the Biomedical Digital Development Forum and Biomedical Industry Expo, we see a new era full of infinite possibilities is coming.

AI is leading the biotech revolution

At the just-concluded 2025 China Biological Fermentation Industry Technology Conference, experts from all over the world gathered to discuss how to use cutting-edge technologies such as artificial intelligence (AI) and synthetic biology to improve the research and development efficiency and production capacity of biological fermentation products. During the conference, several companies shared their successful cases in AI-assisted drug design, precision medicine and personalized treatment program development, indicating that AI technology will play a more important role in the medical and health field in the future.

Policy support contributes to innovative development

At the same time, the news in the government work report on further improving the drug price formation mechanism and supporting the formulation of the innovative drug list has injected a shot in the arm into the whole industry. The national support for the research and development of innovative drugs is constantly increasing, which not only helps to improve the international competitiveness of China’s biomedical enterprises, but also brings more hope for the majority of patients to cure diseases. In this context, more and more enterprises begin to pay attention to and invest in the research and development of innovative drugs, looking forward to showing their latest achievements in the upcoming biomedical digital Development forum.

Digital transformation drives industrial upgrading

With the development of digital technology, the biomedical industry is also undergoing a profound digital transformation. Every step, from drug discovery to clinical trials to the final product launch, is being redefined. Especially in the current big data and cloud computing environment, enterprises can more efficiently manage R & D processes, reduce R & D and development costs, and accelerate the speed of products to market. For example, in the practice of leading enterprises such as Fosun Pharma, AI technology has been widely used in all aspects of drug research and development, which greatly improves the efficiency and success rate of research and development.

Looking forward to the future

Looking ahead, with the further application of AI technology and the continuous optimization of the policy environment, we have reason to believe that the biotech industry will usher in unprecedented opportunities for development. It all signals a brighter future, both for companies working on breakthrough therapy research, and for patients looking for better treatments.

Let’s look forward to witnessing the birth of more innovative achievements and opening a new chapter of biotechnology in the upcoming Biomedical Digital Development Forum and Biomedical Industry Expo!